June 17, 2025

Surgery Partners, Inc. (SGRY) Stock Analysis: Exploring a 35% Potential Upside with Strong Buy Ratings

Investors with an eye on the healthcare sector might find Surgery Partners, Inc. (NASDAQ: SGRY) an intriguing opportunity, especially considering its potential upside of 35.36% based..

Golden Matrix builds under-the-radar scale

Discover how Golden Matrix Group is reshaping the iGaming landscape quietly yet effectively, leveraging strategic expansion and local expertise across key markets...

Harmony Biosciences Holdings (HRMY) Stock Analysis: A 56.70% Potential Upside Amidst Promising Neurological Therapeutics

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY), a dynamic player in the healthcare sector with a focus on biotechnology, continues to capture investor interest with its innovative..

Merus N.V. (MRUS) Stock Analysis: A 69% Upside Potential in the Biotech Sector

Merus N.V. (NASDAQ: MRUS), a clinical-stage biotechnology firm based in the Netherlands, is garnering significant attention in the investor community. With a promising pipeline of innovative..

Acadia Healthcare Company, Inc. (ACHC): Analyst Consensus Suggests Over 100% Upside Potential

Investors looking for opportunities in the healthcare sector should take a closer look at Acadia Healthcare Company, Inc. (NASDAQ: ACHC). With a market cap of $1.95..

Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: Biotechnology Growth with 36% Potential Upside

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM), a dynamic player in the biotechnology sector, has been making waves with its innovative approach to treating rare and orphan diseases...

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: Exploring a 22.66% Potential Upside in CNS Therapeutics

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a prominent player in the biopharmaceutical industry, has carved a niche with its focus on developing and commercializing medicines targeting central..

CRISPR Therapeutics AG (CRSP) Stock Analysis: A Biotech Powerhouse with a 96.41% Potential Upside

CRISPR Therapeutics AG (NASDAQ: CRSP) stands at the forefront of biotechnology innovation, carving a niche in the dynamic sector with its revolutionary CRISPR/Cas9 gene-editing platform. With..

SpringWorks Therapeutics, Inc. (SWTX) Stock Analysis: Unveiling the Biotech Innovator’s Growth Potential

SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) stands as a noteworthy player in the biotechnology sector, with a market capitalization of $3.53 billion. This commercial-stage biopharmaceutical company is..

Privia Health Group, Inc. (PRVA) Stock Analysis: A 32.59% Upside Potential Awaits Investors

Privia Health Group, Inc. (NASDAQ: PRVA), a prominent player in the healthcare sector with a focus on health information services, presents an enticing opportunity for investors...

Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis: A Potential 142% Upside in the Biotech Sector

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) presents a compelling opportunity for investors looking to tap into the burgeoning biotechnology sector, particularly in the niche field of rare..

Immunovant, Inc. (IMVT): Investor Outlook on a Promising 180% Upside in the Biotech Sector

Immunovant, Inc. (NASDAQ: IMVT) is capturing investor attention with its compelling potential upside of 180.08%, according to recent analyst ratings. As a clinical-stage biotechnology company, Immunovant..

Arcellx, Inc. (ACLX) Stock Analysis: Exploring a 73.53% Upside Potential in Biotech

Arcellx, Inc. (NASDAQ: ACLX), a promising player in the biotechnology sector, is drawing significant attention from investors with its impressive potential for growth and innovation in..

Alvotech (ALVO) Stock Analysis: Unveiling a 92.72% Potential Upside in the Biosimilar Market

For investors seeking opportunities in the healthcare sector, Alvotech (NASDAQ: ALVO) presents a compelling case with a notable potential upside of 92.72%. This Luxembourg-based company is..

Scholar Rock Holding Corporation (SRRK) Investor Outlook: A 54.58% Potential Upside Beckons

Scholar Rock Holding Corporation (NASDAQ: SRRK), a dynamic player in the biotechnology sector, has piqued investor interest with its promising pipeline in the healthcare industry. Headquartered..

Metsera, Inc. (MTSR) Stock Analysis: Exploring a Promising 86% Upside in Biotechnology

Metsera, Inc. (MTSR), a clinical-stage biotechnology company, is making waves in the healthcare sector with its innovative approach to tackling obesity and related disorders. Headquartered in..

Amedisys Inc (AMED) Investor Outlook: Navigating Market Challenges in the Healthcare Sector

Amedisys Inc (AMED), a prominent player in the healthcare sector, continues to attract attention from investors seeking opportunities in the medical care facilities industry. With a..

PROCEPT BioRobotics (PRCT) Stock Analysis: A 27% Potential Upside Amid Robust Revenue Growth

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) has been a standout performer in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $3.34..

Ferro-Alloy Resources advances strategic Balasausqandiq partnership

Ferro-Alloy Resources is advancing its strategic ambitions through a key partnership with CC6 on the Balasausqandiq vanadium project, enhancing its market position...

Norcros Builds Momentum in FY25 with Strong UK Performance – Equity Development

Full-year results for FY25, underscore the early success of its strategic initiatives..
Search

Funds

June 17, 2025

Golden Matrix builds under-the-radar scale

Discover how Golden Matrix Group is reshaping the iGaming landscape quietly yet effectively, leveraging strategic expansion and local expertise across key markets...

Ferro-Alloy Resources advances strategic Balasausqandiq partnership

Ferro-Alloy Resources is advancing its strategic ambitions through a key partnership with CC6 on the Balasausqandiq vanadium project, enhancing its market position...

Norcros Builds Momentum in FY25 with Strong UK Performance – Equity Development

Full-year results for FY25, underscore the early success of its strategic initiatives..
Search

Funds

June 17, 2025

FTSE 100

Funds